SCHEMBL5081

SCHEMBL5081

CC(C)Oc1ccc(N2CC[C@]3(CC[C@@](O)(c4ccsc4)CC3)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.41
USP2 O75604 5/20 0.35
ALDH1A1 P00352 5/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPT P10636 2/20 0.35
ALOX15 P16050 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
FFAR4 Q5NUL3 4/20 0.35
CHRM1 P11229 1/20 0.33
CYP3A4 P08684 5/20 0.32
CYP2C9 P11712 4/20 0.32
CYP1A2 P05177 3/20 0.32
HIF1A Q16665 3/20 0.32
MAPK1 P28482 3/20 0.32
MEN1 O00255 2/20 0.32
CYP2C19 P33261 2/20 0.32
LIPE Q05469 4/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569 0.79 USP2 (0.41) USP2ALDH1A1KMT2AHSD17B10MAPT
SCHEMBL1589224 0.77 LIPE (0.56) SIGMAR1LIPE
SCHEMBL1589223 0.77 LIPE (0.56) SIGMAR1LIPE
SCHEMBL5546 0.75 LIPE (0.44) USP2ALDH1A1KMT2AHSD17B10MAPT
SCHEMBL6125 0.74 FFAR4 (0.41) USP2ALDH1A1KMT2AHSD17B10MAPT
SCHEMBL1310070 0.68
SCHEMBL5301 0.65 EPHX2 (0.42) FFAR4LIPE
SCHEMBL5019 0.62 SLC6A4 (0.49) LIPE
SCHEMBL20000542 0.62 MAPT (0.66) SIGMAR1USP2ALDH1A1KMT2AHSD17B10
SCHEMBL1309402 0.61 CHRM1 (0.42) SIGMAR1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed